Background: Transcatheter aortic valve replacement (TAVR) has been introduced into US
clinical practice with efforts to optimize outcomes and minimize the learning curve …

Importance Transcatheter aortic valve replacement (TAVR) was approved by the US Food
and Drug Administration for the treatment of severe, symptomatic aortic stenosis and …

Objectives: The authors aimed to determine the procedural learning curve and minimum
annual institutional volumes associated with optimum clinical outcomes for transcatheter …

Abstract Background: The Society of Thoracic Surgeons (STS)/American College of
Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry has been a joint initiative of …

Background During the introduction of transcatheter aortic-valve replacement (TAVR) in the
United States, requirements regarding procedural volume were mandated by the Centers for …

Importance Introducing new medical devices into routine practice raises concerns because
patients and outcomes may differ from those in randomized trials. Objective To update the …

Abstract The STS-ACC TVT Registry (Society of Thoracic Surgeons–American College of
Cardiology Transcatheter Valve Therapy Registry) from 2011 to 2019 has collected data on …

Background—In patients with severe aortic stenosis, transcatheter aortic valve replacement
(TAVR) improves survival when compared with nonsurgical therapy but with higher in …

Transcatheter aortic valve implantation (TAVI) is associated with a significant learning curve.
There is paucity of data regarding the effect of hospital volume on outcomes after TAVI. This …

Background: Randomized trials support the use of transcatheter aortic valve replacement
(TAVR) for the treatment of aortic stenosis in high-and intermediate-risk patients, but the …